Evaluation of CG-100 Intraluminal Bypass Device

You may be eligible if

• 1. Willing to comply with protocol-specified follow-up evaluations
• 2. 22-75 (inclusive) years of age at screening
• 3. Diagnosed with colorectal cancer
• 4. Has been informed of the nature of the study, agrees to its provisions, and has provided written informed consent